Viewing Study NCT03399669


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT03399669
Status: UNKNOWN
Last Update Posted: 2018-01-16
First Post: 2018-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation
Sponsor: Samsung Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2014-11-095
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators